Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Prepare Now to Survive MACRA

Kelly Tyrrell  |  Issue: July 2016  |  July 5, 2016

“We’ll see what emerges,” he adds.

ACR representatives recently met with Congressional staff to share concerns and ideas, and Dr. Adams says the feedback they received was “encouraging.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

However, the cost to rheumatologists, particularly those in small or solo practices, must be taken into account, Drs. Herzig and Adams both say.

“Some doctors will look at their Medicare income, see what percentage of Medicare they have in their practice and decide whether a 4% cut is worth it or not,” Dr. Herzig says. “What doctors need to know is they need to have real control of their budget. If they know what their budget is and look at what percentage of Medicare is their budget, they can figure out what that means to them.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

For example, starting in 2019, if a practitioner receives $300,000 a year in Medicare reimbursements, a 4% loss is $12,000. “That cost might be absorbed,” Dr. Herzig says. “However, the penalty rises each year.

“Doctors have to get moving now,” he adds. “There is no time to waste.”

Looking Forward
In addition to knowing their budget, rheumatologists should look for ways to work together, Drs. Adams, Herzig, White and Kazi all say.

“We’re not going to survive as lone rangers, independently putting out every brush fire that comes along,” Dr. Adams says. “This movement toward quality and cost control in medicine is too big for any one doctor or small group of doctors to deal with. I think the ACR’s efforts are vitally important, and members really need to support and contribute to it in terms of leadership.”

On June 24, 2016, the ACR submitted a letter to the CMS lauding the promise of MACRA while also expressing deep concerns over some aspects of the reimbursement overhaul.3 The comments reflect many of those shared by Drs. Adams, Herzig, White and Kazi. In particular, the ACR believes the benchmark timeline for MACRA measurement to be “daunting,” and would like to see additional exceptions and consideration made for small and solo practices.

The key issues, the ACR wrote to the CMS, concern timing and complexity of the requirements, the lack of APMs for which rheumatologists appear to be qualified and the exclusion of Part D medication costs from resource use calculations.

“We are pleased to provide comments on a number of the complex issues raised within the rule,” wrote Dr. Von Feldt in the letter to the CMS. “As a general principle, we encourage CMS to be mindful of our ability to treat and care for patients with chronic and rheumatic diseases.”

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:Professional Topics Tagged with:Centers for Medicare & Medicaid Services (CMS)MACRAMedicareRISE

Related Articles

    How to Survive MACRA

    April 19, 2017

    The year 2015 brought the end of the much-maligned Sustainable Growth Rate (SGR), sometimes known as the “doc fix.” The SGR established limits on Medicare reimbursement for physicians, and each year, physicians and those lobbying on their behalf were forced to stave off drastic cuts to their payments. “The SGR was Congress’s attempt to control…

    MACRA Has Arrived—& What You Do Now Counts

    October 4, 2017

    Changes to reimbursement introduced by the Medicare Access and CHIP Reauthorization Act (MACRA) will affect your Medicare income for 2019. “Rheumatologists generally know that MACRA is up and running,” says Angus Worthing, MD, FACR, FACP, clinical assistant professor of rheumatology at Georgetown University Medical Center and chair of the ACR’s Government Affairs Committee. “Virtually every…

    Medicare Access and CHIP Reauthorization Act of 2015: What You Should Know

    April 15, 2016

    There is no denying that the past few years have been a time of immense change in healthcare. Sweeping pieces of legislation have fundamentally altered the way we practice medicine. This is absolutely the case when it comes to the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA, for short). MACRA is an enormous…

    MACRA: More Points, Smarter Future

    December 14, 2016

    As the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) is implemented in January with new models for quality-based reimbursement payments, rheumatologists must seize control of how they will be paid now—and in the future. This message was stressed by speakers during Holy MACRA! How to Survive and Thrive in the Era of MACRA,…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences